Get the StoQuant digest — free
Free StoQuant digest by email. No account needed.
See today's research picks.
MESO vs OCS — Stock Comparison
Compare MESO and OCS side-by-side on StoQuant: MESO Q-Score 45 vs OCS 27; analyst signal 65 vs 77. Plus alt data signals, insider buying, catalysts, strategic edges, short interest, social sentiment, and macro context.
Side-by-side snapshot
- MESO — Mesoblast Limited · Health Care · market cap $1.59B · Q-Score verdict Hold (45.0, grade C) · analyst signal 65/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: analyst consensus 43/100, technicals 34/100. Full MESO research.
- OCS — Oculis Holding AG · Health Care · market cap $487M · Q-Score verdict Sell (27.0, grade D) · analyst signal 77/100 — Wall Street ratings and target changes turned into a 0-100 score · strongest signals: analyst consensus 81/100, technicals 3/100. Full OCS research.
What you can compare
- Q-Score: StoQuant's composite 0–100 rating based on 140+ financial signals.
- Alt data signals: Google Trends, EDGAR 8-K filings, job postings, and more.
- Insider activity: Cluster scores and recent Form 4 buying.
- Catalysts: Earnings, analyst changes, M&A, clinical trials, and SEC events.
- Strategic edges: Competitive moat and durable advantage analysis.
- Short interest & social sentiment: Short % float, social mention volume, and bullish/bearish breakdown.
- Macro context: Market regime and sector rotation alignment.
Deep dive: MESO research · OCS research. Sign in to StoQuant to run live comparisons for any tickers. Sign up free →
Register founding interest — Pro $29/mo or Power $79/mo
Paid plans aren’t for sale yet. Leave your email to lock founding pricing (Pro $29, Power $79); we’ll reach out personally.